Financial reports
ARS
2023 FY
Annual report to shareholders
10 Apr 24
10-K
2023 FY
Annual report
13 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
13 Apr 23
10-K
2022 FY
Annual report
20 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
11 May 22
Current reports
Registration and prospectus
POS EX
Additional exhibits for listing
15 Apr 24
424B3
Prospectus supplement
15 Apr 24
424B3
Prospectus supplement
12 Apr 24
POS AM
Prospectus update (post-effective amendment)
2 Apr 24
POS EX
Additional exhibits for listing
15 Mar 24
424B3
Prospectus supplement
15 Mar 24
POS EX
Additional exhibits for listing
15 Feb 24
424B3
Prospectus supplement
15 Feb 24
POS EX
Additional exhibits for listing
16 Jan 24
424B3
Prospectus supplement
16 Jan 24
Proxies
DEFA14A
Additional proxy soliciting materials
10 Apr 24
DEFA14A
Additional proxy soliciting materials
10 Apr 24
DEF 14A
Definitive proxy
10 Apr 24
DEFA14A
Additional proxy soliciting materials
6 Jul 23
DEFA14A
Additional proxy soliciting materials
13 Apr 23
DEF 14A
Definitive proxy
13 Apr 23
DEFA14A
Additional proxy soliciting materials
30 Jun 22
DEFA14A
Additional proxy soliciting materials
12 Apr 22
DEF 14A
Definitive proxy
12 Apr 22
DEFA14A
Additional proxy soliciting materials
9 Apr 21
Other
EFFECT
Notice of effectiveness
15 Apr 24
EFFECT
Notice of effectiveness
17 Apr 23
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
20 Mar 23
UPLOAD
Letter from SEC
3 Nov 22
CORRESP
Correspondence with SEC
2 Nov 22
UPLOAD
Letter from SEC
14 Oct 22
EFFECT
Notice of effectiveness
24 May 22
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
11 May 22
EFFECT
Notice of effectiveness
4 May 22
CORRESP
Correspondence with SEC
28 Apr 22